Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,604.50
Bid: 1,604.00
Ask: 1,604.50
Change: -5.50 (-0.34%)
Spread: 0.50 (0.031%)
Open: 1,611.50
High: 1,615.50
Low: 1,599.50
Prev. Close: 1,610.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Thursday broker round-up UPDATE

Thu, 03rd Apr 2014 09:05

Associated British Foods: Citi increases target price from 2350p to 3000p, while its neutral rating remains unchanged.Booker Group: Investec shifts target price from 172p to 178p retaining a buy recommendation.BSkyB: HSBC Holdings moves target price from 600p to 610p, while keeping its underweight rating.Burberry: Deutsche Bank cuts target price from 1600p to 1575p maintaining its hold recommendation.CSR: N+1 Singer raises target price to 777p and reiterates its hold recommendation.Daily Mail & General Trust: Jefferies increases target price from 800p to 1016p and maintains a buy recommendation.Direct Line Group: Berenberg ups target price from 230p to 254p and keeps a hold recommendation.easyJet: JP Morgan raises target price from 1725p to 1965p and reiterates an overweight rating.First Group: JP Morgan lowers target price from 165p to 156p and keeps an overweight rating.Glaxo Smith Kline: JP Morgan reduces target price from 1750p to 1700p leaving its neutral rating unchanged.Greene King: JP Morgan lowers target price from 960p to 940p maintaining a neutral rating.Heritage Oil: UBS reduces target price from 325p to 300p, while its buy recommendation is kept.HSBC Holdings: Investec reduces target price from 745p to 640p and downgrades from buy to hold.Hyder Consulting: Investec upgrades from hold to buy with a target price of 510p.Ithaca Energy: Canaccord Genuity lowers target price from 180p to 175p, while its buy recommendation is kept.Lonmin: RBC Capital cuts target price from 370p to 360p and retains an outperform rating.Marston's: JP Morgan reduces target price from 180p to 155p staying with its neutral rating.McBride: Investec places both its target price (prev.: 120p) and its buy recommendation under review. Panmure Gordon cuts target price from 120p to 100p downgrading from buy to hold.Merlin Entertainment: Deutsche Bank raises target price from 395p to 430p and stays with its buy recommendation.Minoan Group: WH Ireland shifts target price from 20p to 28p and stays with its speculative buy recommendation.Mitchells & Butlers: JP Morgan increases target price from 460p to 530p upgrading to overweight.Parkmead Group: Westhouse Securities initiates with a target price of 400p and a buy recommendation.Pennon Group: UBS takes target price from 725p to 795p and reiterates a buy recommendation.Polymetal International: Citi lowers target price from 452p to 450p and stays with its sell recommendation.Resolution: Canaccord Genuity reduces target price from 375p to 300p maintaining a hold recommendation.Restaurant Group: JP Morgan shifts target price from 750p to 755p retaining an overweight rating.Rotork: RBC Capital initiates with a target price of 2800p and a neutral rating.Severn Trent: UBS takes target price from 1825p to 1885p leaving its neutral rating unaltered.Smith & Nephew: Numis downgrades from add to hold with a target price of 1000p.Spirax-Sarco Engineering: RBC Capital initiates with a target price of 3250p and an outperform rating.Tullow Oil: UBS cuts target price from 925p to 900p, while upgrading from neutral to buy.United Utilities: UBS ups target price from 750p to 775p keeping a neutral rating.Wincanton: Investec upgrades from hold to buy with a target price of 155p.
More News
11 Jun 2024 14:31

Zantac litigation fears overdone at GSK, says Shore Capital

(Sharecast News) - Volatile moves in GSK's share price are likely to persist in the near term as a result of ongoing Zantac-related litigation, but the long-term investment case is "still appealing", according to Shore Capital, which kept a 'buy' rating on the stock.

Read more
11 Jun 2024 09:32

TOP NEWS: GSK takes first steps to appeal Zantac ruling in Delaware

(Alliance News) - GSK PLC on Tuesday said it has taken the first steps to seek appeal of a ruling by the Delaware Superior Court in regard to its discontinued heartburn drug Zantac.

Read more
11 Jun 2024 09:12

LONDON MARKET OPEN: FTSE 100 up; UK unemployment rises to 4.4%

(Alliance News) - Stock prices in London opened higher on Tuesday, after a difficult day for markets on Monday amid the EU election fallout.

Read more
11 Jun 2024 07:52

LONDON BRIEFING: FTSE 100 called up despite unemployment rise

(Alliance News) - The FTSE 100 in London was called to open higher on Tuesday, after data showed that unemployment in the UK unexpectedly rose.

Read more
11 Jun 2024 07:22

GSK launches appeal to recent Zantac ruling

(Sharecast News) - GSK has started the process of appealing a recent decision by the Delaware Superior Court regarding the ongoing Zantac, or ranitidine, litigation, it announced on Tuesday.

Read more
11 Jun 2024 00:32

GSK asks to appeal Delaware ruling allowing Zantac cases to go forward

June 10 (Reuters) -

Read more
10 Jun 2024 22:49

Latest trial over Zantac cancer claims called off as plaintiff drops case

June 10 (Reuters) - A woman who claimed in a lawsuit that GSK's discontinued heartburn drug Zantac caused her breast cancer dropped her case shortly before it was set to go to trial in Illinois state court on Monday, the company announced.

Read more
10 Jun 2024 19:00

TOP NEWS: GSK welcomes dismissal of Zantac case in Illinois

(Alliance News) - GSK PLC on Monday welcomed the dismissal of a case in the US concerning the heartburn drug, Zantac, which was due to start on Monday.

Read more
10 Jun 2024 12:42

EU to secure 40 million avian flu vaccines for 15 countries - officials

BRUSSELS, June 10 (Reuters) - The EU will sign a contract on Tuesday to secure over 40 million doses of a preventative avian flu vaccine for 15 countries with the first shipments heading to Finland, EU officials said on Monday.

Read more
10 Jun 2024 08:39

GSK gets FDA approval for Arexvy vax in 50-59 year olds at risk of RSV

(Alliance News) - GSK PLC on Monday announced that the US Food & Drug Administration has approved an expanded age indication for its respiratory syncytial virus vaccine.

Read more
10 Jun 2024 07:37

LONDON BRIEFING: FTSE called down amid political uncertainty in EU

(Alliance News) - Stocks in London are called to open lower on Monday, setting off the week on the backfoot, with eyes on the US Federal Reserve's latest interest rate decision.

Read more
10 Jun 2024 07:17

GSK's Arexvy vaccine approved for wider age range

(Sharecast News) - US regulators have approved the use of GSK's Arexvy vaccine for a younger age group, the biopharma group announced on Monday.

Read more
7 Jun 2024 19:34

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, June 7 (Reuters) - The outbreak of bird flu in U.S. dairy cows has now been confirmed in Minnesota and Iowa, bringing to 11 the total number of affected states, which have been encouraged to ramp up testing efforts at the request of government officials.

Read more
5 Jun 2024 09:52

LONDON BROKER RATINGS: Berenberg raises Taylor Wimpey to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

Read more
3 Jun 2024 17:20

European shares kick-off June on a high note in anticipation of ECB rate cut

GSK tumbles as Zantac lawsuits allowed to proceed

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.